Bethanie Simmons Becil
Psychiatric/Mental Health · Jacksonville, FLNPI 1497058879
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $623,071 of the $782,327 with a category attached, or 79.6%. AbbVie accounts for 78.6% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $220,024, 2.8 times the $77,765 reported in 2021. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,233 payments — averaging $634.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$615K
- Axsome Therapeutics, Inc.$166K
- Corium, LLC$175
- Otsuka America Pharmaceutical, Inc.$159
- Takeda Pharmaceuticals U.S.A., Inc.$62
- Neos Therapeutics, LP$46
- plus $169 from 8 others
What the payments were for
- Consulting fees$70,5799%
- Speaking & faculty fees$623,07180%
- Travel & lodging$70,5499%
- Food & beverage$18,1232%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 928 | $615,242 |
| Axsome Therapeutics, Inc. | 278 | $166,475 |
| Corium, LLC | 9 | $175 |
| Otsuka America Pharmaceutical, Inc. | 4 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Neos Therapeutics, LP | 2 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $30 |
| Tris Pharma Inc | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Noven Pharmaceuticals, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$782,327 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 23 | $36,602 |
| Trazodone Hcl | 15 | $606 |
| Clonazepam | 18 | $123 |
| Alprazolam | 18 | $72 |
| Fluoxetine Hcl | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $615,242 | $36,60223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Jacksonville
- Karen McNeelyJacksonville$13K
- Roger RiveraKissimmee$1.6M
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.